Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Pasic

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
American Journal of Hematology|April 16, 2026
The Role of Allogeneic Hematopoietic Cell Transplantation in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase InhibitorsIvan Pasic, Jeffrey H Lipton
Leukemia Research|January 31, 2017
Current approach to the treatment of chronic myeloid leukaemiaIvan Pasic, Jeffrey H Lipton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 24, 2023
Keerat Grewal, Elizabeth Herrity, Ivan Pasic
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 11, 2023
Tumour lysis syndromeKeerat Grewal, Elizabeth Herrity, Ivan Pasic
Cell Cycle (Georgetown, Tex.)|May 25, 2010
The oncogenic and growth-suppressive functions of the integrin-linked kinase are distinguished by JNK1 expression in human cancer cellsAdam David Durbin, Ivan Pasic, Dennis K Wong, et al.
Leukemia & Lymphoma|April 8, 2021
Inferior outcomes with reduced intensity conditioning followed by allogeneic hematopoietic cell transplantation in fit individuals with acute lymphoblastic leukemia: a Canadian single-center study and a comparison to registry dataIvan Pasic, Kristjan Paulson, Graham Dozois, et al.
Bone Marrow Transplantation|June 25, 2022
Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomesKayla Madsen, Karyne Pelletier, Gabrielle Côté, et al.
Acta Haematologica|February 8, 2024
Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with DefibrotideRam Vasudevan Nampoothiri, Lisa Avery, Ivan Pasic, et al.
Transplantation and Cellular Therapy|January 23, 2026
Impact of pretransplant blinatumomab on post-transplant outcomes in B-cell acute lymphoblastic leukemia: a systematic review and meta-analysisSergio Rodriguez-Rodriguez, Anna Olive, Fausto Alfredo Rios-Olais, et al.
Transplantation and Cellular Therapy|April 28, 2026
Early initiation of defibrotide is associated with better survival in sinusoidal obstruction syndrome/veno-occlusive disease in adults: experience from two Canadian centersNihar Desai, Jean-François Tourigny, Carol Chen, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|April 16, 2026
The Role of Allogeneic Hematopoietic Cell Transplantation in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase InhibitorsIvan Pasic, Jeffrey H Lipton
Leukemia Research|January 31, 2017
Current approach to the treatment of chronic myeloid leukaemiaIvan Pasic, Jeffrey H Lipton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 24, 2023
Keerat Grewal, Elizabeth Herrity, Ivan Pasic
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 11, 2023
Tumour lysis syndromeKeerat Grewal, Elizabeth Herrity, Ivan Pasic
Cell Cycle (Georgetown, Tex.)|May 25, 2010
The oncogenic and growth-suppressive functions of the integrin-linked kinase are distinguished by JNK1 expression in human cancer cellsAdam David Durbin, Ivan Pasic, Dennis K Wong, et al.
Leukemia & Lymphoma|April 8, 2021
Inferior outcomes with reduced intensity conditioning followed by allogeneic hematopoietic cell transplantation in fit individuals with acute lymphoblastic leukemia: a Canadian single-center study and a comparison to registry dataIvan Pasic, Kristjan Paulson, Graham Dozois, et al.
Bone Marrow Transplantation|June 25, 2022
Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomesKayla Madsen, Karyne Pelletier, Gabrielle Côté, et al.
Acta Haematologica|February 8, 2024
Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with DefibrotideRam Vasudevan Nampoothiri, Lisa Avery, Ivan Pasic, et al.
Transplantation and Cellular Therapy|January 23, 2026
Impact of pretransplant blinatumomab on post-transplant outcomes in B-cell acute lymphoblastic leukemia: a systematic review and meta-analysisSergio Rodriguez-Rodriguez, Anna Olive, Fausto Alfredo Rios-Olais, et al.
Transplantation and Cellular Therapy|April 28, 2026
Early initiation of defibrotide is associated with better survival in sinusoidal obstruction syndrome/veno-occlusive disease in adults: experience from two Canadian centersNihar Desai, Jean-François Tourigny, Carol Chen, et al.
Pageof 10